Cargando…

Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant

Colorectal cancer is a molecularly heterogeneous disease. Responses to genotoxic chemotherapy in the adjuvant or palliative setting vary greatly between patients, and colorectal cancer cells often resist chemotherapy by evading apoptosis. Antagonists of an inhibitor of apoptosis proteins (IAPs) can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fichtner, Michael, Bozkurt, Emir, Salvucci, Manuela, McCann, Christopher, McAllister, Katherine A., Halang, Luise, Düssmann, Heiko, Kinsella, Sinéad, Crawford, Nyree, Sessler, Tamas, Longley, Daniel B., Prehn, Jochen H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705699/ https://www.ncbi.nlm.nih.gov/pubmed/33257690 http://dx.doi.org/10.1038/s41419-020-03232-z

Ejemplares similares

Targeting triple-negative breast cancers with the Smac-mimetic birinapant
por: Lalaoui, Najoua, et al.
Publicado: (2020)

Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations
por: Colombo, Marika, et al.
Publicado: (2020)

SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway
por: Ding, Jun, et al.
Publicado: (2020)

Heterogeneous responses to low level death receptor activation are explained by random molecular assembly of the Caspase-8 activation platform
por: Matveeva, Anna, et al.
Publicado: (2019)

SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma
por: Crawford, N, et al.
Publicado: (2013)

Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003)

Future Therapeutic Directions for Smac-Mimetics
por: Morrish, Emma, et al.
Publicado: (2020)

TRAIL signaling promotes entosis in colorectal cancer
por: Bozkurt, Emir, et al.
Publicado: (2021)

New light on Smac mimetics and breast cancer
por: Cornmark, L, et al.
Publicado: (2016)

Hyperosmotic stress enhances cytotoxicity of SMAC mimetics
por: Bittner, Sebastian, et al.
Publicado: (2017)

SMAC Mimetics as Therapeutic Agents in HIV Infection
por: Molyer, Bengisu, et al.
Publicado: (2021)

BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes
por: Pfeiffer, S, et al.
Publicado: (2015)

Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic
por: Balakrishnan, Kumudha, et al.
Publicado: (2016)

Redox regulation of Smac mimetic-induced cell death
por: Fulda, Simone
Publicado: (2015)

Smac-mimetics reduce numbers and viability of human osteoclasts
por: Moen, Ingrid Nyhus, et al.
Publicado: (2021)

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)
por: Salvucci, Manuela, et al.
Publicado: (2022)

The role of SMAC mimetics in regulation of tumor cell death and immunity
por: Emeagi, Perpetua U., et al.
Publicado: (2012)

Regulation of cancer stem-like cell differentiation by Smac mimetics
por: Fulda, Simone
Publicado: (2014)

Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
por: Zhao, Xiao-Yun, et al.
Publicado: (2020)

Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stress
por: Abhari, Behnaz Ahangarian, et al.
Publicado: (2019)

SMG1 and NIK regulate apoptosis induced by Smac mimetic compounds
por: Cheung, H H, et al.
Publicado: (2011)

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
por: Awasthi, Niranjan, et al.
Publicado: (2011)

Smac mimetics and innate immune stimuli synergize to promote tumor death
por: Beug, Shawn T., et al.
Publicado: (2014)

The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
por: Huang, Qingsheng, et al.
Publicado: (2019)

Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis
por: Kulíšková, Petra, et al.
Publicado: (2023)

Correction: Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stress
por: Abhari, Behnaz Ahangarian, et al.
Publicado: (2020)

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
por: Zakaria, Z, et al.
Publicado: (2016)

Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
por: Jinesh G., Goodwin, et al.
Publicado: (2012)

Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells
por: Czaplinski, Sebastian, et al.
Publicado: (2015)

Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer
por: Hagenbuchner, Judith, et al.
Publicado: (2019)

SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages
por: Campbell, Grant R., et al.
Publicado: (2020)

Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
por: Lecis, D, et al.
Publicado: (2010)

CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex
por: Maas, C, et al.
Publicado: (2013)

Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity
por: Lecis, D, et al.
Publicado: (2013)

Structural Insight into Inhibitor of Apoptosis Proteins Recognition by a Potent Divalent Smac-Mimetic
por: Cossu, Federica, et al.
Publicado: (2012)

PKC activation sensitizes basal-like breast cancer cell lines to Smac mimetics
por: Cornmark, L, et al.
Publicado: (2016)

Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis
por: Welsh, Kate, et al.
Publicado: (2016)

The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma
por: Chen, Zide, et al.
Publicado: (2018)

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
por: Beug, Shawn T., et al.
Publicado: (2017)

Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
por: Shekhar, Tanmay M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ujh1cortkeghci5j87lg7i6kmt